Hyperoxia causes vasoconstriction in most tissues, by mechanisms that are not fully understood. We investigated microvascular effects of breathing 100% oxygen in healthy volunteers, using iontophoresis to deliver acetylcholine (ACh) and sodium nitroprusside (SNP). Aspirin and vitamin C were used to test for involvement of prostaglandins and radical oxygen species. Forearm skin perfusion was measured using laser Doppler perfusion imaging. Results were analysed using dose-response modelling. The response to ACh was reduced by 30% during oxygen breathing compared to air breathing [0.98 (0.81–1.15) PU vs. 1.45 (1.30–1.60) PU, p < 0.001]. ED50 values were unchanged [2.25 (1.84–2.75) vs. 2.21 (1.79–2.74), not significant]. Aspirin pre-treatment abolished the difference in response between oxygen breathing and air breathing [maximum: 1.03 (0.90–1.16) vs. 0.89 (0.77–1.01), not significant; ED50: 1.83 (1.46–2.30) vs. 1.95 (1.65–2.30), not significant]. ACh-mediated vasodilatation during 100% oxygen breathing was partially restored after pre-treatment with vitamin C. Breathing 100% oxygen did not change the microvascular response to SNP [1.45 (1.28–1.62) vs. 1.40 (1.26–1.53), not significant]. These results favour the hypothesis that hyperoxic vasoconstriction is mediated by inhibition of prostaglandin synthesis. Radical oxygen species may be involved as vitamin C, independently of aspirin, partially restored ACh-mediated vasodilatation during hyperoxia.

Keywords:
Acetylcholine, Perfusion, Hyperoxia, Iontophoresis, Prostaglandins, Radical oxygen species, Sodium nitroprusside
1.
Daly WJ, Bondurant S: Effects of oxygen on the heart rate, blood pressure, and cardiac index of normal men-resting, with reactive hyperemia, and after atropine. J Clin Invest 1962;41:126–134.
2.
Milone SD, Newton GE, Parker JD: Hemodynamic and biochemical effects of 100% oxygen breathing in humans. Can J Physiol Pharmacol 1999;77:124–130.
3.
Rousseau A, Bak Z, Janerot-Sjoberg B, Sjoberg F: Acute hyperoxemia-induced effects on regional blood flow, oxygen consumption and central circulation in man. Acta Physiol Scand 2005;183:231–240.
4.
Waring WS, Thomson AJ, Adwani SH, Rosseel AJ, Potter JF, Webb DJ, Maxwell SR: Cardiovascular effects of acute oxygen administration in healthy adults. J Cardiovasc Pharmacol 2003;2:245–250.
5.
Crawford P, Good PA, Gutierrez E, Feinberg JH, Boehmer JP, Silber DH, Sinoway LI: Effects of supplemental oxygen on forearm vasodilation in humans. J Appl Physiol 1997;2:1601–1606.
6.
Kenmure AC, Beatson JM, Cameron AJ, Horton PW: Effects of oxygen on myocardial blood flow and metabolism. Cardiovasc Res 1971;5:483–489.
7.
Joachimsson PO, Sjoberg F, Forsman M, Johansson M, Ahn HC, Rutberg H: Adverse effects of hyperoxemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:812–819.
8.
Kiss B, Polska E, Dorner G, Polak K, Findl O, Mayrl GF, Eichler HG, Wolzt M, Schmetterer L: Retinal blood flow during hyperoxia in humans revisited: concerted results using different measurement techniques. Microvasc Res 2002;64:75–85.
9.
Watson NA, Beards SC, Altaf N, Kassner A, Jackson A: The effect of hyperoxia on cerebral blood flow: a study in healthy volunteers using magnetic resonance phase-contrast angiography. Eur J Anaesthesiol 2000;17:152–159.
10.
Ellsworth ML, Forrester T, Ellis CG, Dietrich HH: The erythrocyte as a regulator of vascular tone. Am J Physiol 1995;269:H2155–H2161.
11.
Amin HM, Camporesi EM, Cohen D, Hakim TS, Kaniewski WS: Effects of acute exposure to hyperbaric oxygen on the rheology and morphology of the red blood cells in the rat. Microvasc Res 1995;50:417–428.
12.
Messina EJ, Sun D, Koller A, Wolin MS, Kaley G: Increases in oxygen tension evoke arteriolar constriction by inhibiting endothelial prostaglandin synthesis. Microvasc Res 1994;48:151–160.
13.
Yamazaki F: Hyperoxia attenuates endothelial-mediated vasodilation in the human skin. J Physiol Sci 2007;57:81–84.
14.
Mildenberger E, Siegel G, Versmold HT: Prostanoids contribute to the oxygen-dependent regulation of vascular tone of human umbilical vein. J Perinat Med 2004;32:149–154.
15.
Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. J Appl Physiol 1986;250:H822–H827.
16.
Mak S, Egri Z, Tanna G, Colman R, Newton GE: Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation. Am J Physiol Heart Circ Physiol 2002;282:H2414–H2421.
17.
Wardell K, Jakobsson A, Nilsson GE: Laser Doppler perfusion imaging by dynamic light scattering. IEEE Trans Biomed Eng 1993;40:309–316.
18.
Morris SJ, Shore AC: Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996;496:531–542.
19.
Droog EJ, Henricson J, Nilsson GE, Sjoberg F: A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 2004;67:197–202.
20.
Droog EJ, Sjoberg F: Nonspecific vasodilatation during transdermal iontophoresis-the effect of voltage over the skin. Microvasc Res 2003;65:172–178.
21.
Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR: Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704–3709.
22.
Henricson J, Tesselaar E, Persson K, Nilsson G, Sjöberg F: Assessment of microvascular function by study of the dose-response effects of iontophoretically applied drugs (acetylcholine and sodium nitroprusside) – methods and comparison with in vitro studies. Microvasc Res 2007;73:143–149.
23.
Tesselaar E, Henricson J, Jonsson S, Sjoberg F: A time-response model for analysis of drug transport and blood flow response during iontophoresis of acetylcholine and sodium nitroprusside. J Vasc Res 2008;46:270–277.
24.
Wagner JG: Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man. J Theor Biol 1968;20:173–201.
25.
Clough GF, Gush R: Is it important to model the impact of blood flow on the dose of drugs delivered transcutaneously? J Vasc Res 2009;46:267–269.
26.
Harker L, Fuster U: Pharmacology of platelet inhibitors. J Am Coll Cardiol 1986;8:21B–32B.
27.
Durand S, Tartas M, Bouyé P, Koïtka A, Saumet JL, Abraham P: Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans. J Physiol 2004;561:811–819.
28.
Holowatz LA, Thompson CS, Minson CT, Kenney WL: Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 2005;563:965–973.
29.
Kellogg DL Jr, Zhao JL, Coey U, Green JV: Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 2005;98:629–632.
30.
Medow MS, Glover JL, Stewart JM: Nitric oxide and prostaglandin inhibition during acetylcholine-mediated cutaneous vasodilation in humans. Microcirculation 2008;15:569–579.
31.
Lenasi H, Strucl M: The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity. Eur J Appl Physiol 2008;103:719–726.
32.
Ishii Y, Morita I, Murota S, Kitamura S: Hyperoxia decreases cyclooxygenase activity in endothelial cells. Prostaglandins Leukot Essent Fatty Acids 1993;48:455–461.
33.
Win TS, Marshall JM: Contribution of prostaglandins to the dilation that follows isometric forearm contraction in human subjects: effects of aspirin and hyperoxia. J Appl Physiol 2005;99:45–52.
34.
Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP: Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 2003;98:348–353.
35.
Huang HY, Appel LJ, Croft KD, Miller ER 3rd, Mori TA, Puddey IB: Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 2002;76:549–555.
36.
Sanchez-Moreno C, Cano MP, de Ancos B, Plaza L, Olmedilla B, Granado F, Elez-Martinez P, Martin-Belloso O, Martin A: Pulsed electric fields-processed orange juice consumption increases plasma vitamin C and decreases F2-isoprostanes in healthy humans. J Nutr Biochem 2004;15:601–607.
37.
Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001;38:606–611.
38.
Ulker S, McKeown PP, Bayraktutan U: Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534–539.
39.
Parinandi NL, Kleinberg MA, Usatyuk PV, Cummings RJ, Pennathur A, Cardounel AJ, Zweier JL, Garcia JG, Natarajan V: Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 2003;284:L26–L38.
40.
Yusa T, Crapo JD, Freeman BA: Hyperoxia enhances lung and liver nuclear superoxide generation. Biochim Biophys Acta 1984;798:167–174.
41.
Freeman BA, Crapo JD: Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. Biol Chem 1981;256:10986–10992.
42.
Jaensch S, Cullen L, Raidal SR: Normobaric hyperoxic stress in budgerigars: enzymic antioxidants and lipid peroxidation. Comp Biochem Physiol C Toxicol Pharmacol 2001;128:173–180.
43.
Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ: Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004;59:1016–1019.
44.
Vento M, Asensi M, Sastre J, Lloret A, Garcia-Sala F, Vina J: Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. J Pediatr 2003;142:240–246.
45.
Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107–1113.
46.
Eskurza I, Monahan KD, Robinson JA, Seals DR: Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men. Am J Physiol Heart Circ Physiol 2004;286:H1528–H1534.
47.
Rousseau A, Abdiu A, Sjoberg F: Hyperoxaemia does not change concentrations of serotonin and β-thromboglobulin in blood of healthy humans. Scand J Clin Lab Invest 2004;64:81–85.
48.
Dean JB, Mulkey DK, Henderson RA 3rd, Potter SJ, Putnam RW: Hyperoxia, reactive oxygen species, and hyperventilation: oxygen sensitivity of brain stem neurons. J Appl Physiol 2004;96:784–791.
49.
Hendry RG, Marshall JM: Vasoconstrictor products of cyclo-oxygenase activity limit acetylcholine-induced cutaneous vasodilatation in young men. Clin Sci (Lond) 2004;107:323–330.
50.
Algotsson A, Nordberg A, Winblad B: Influence of age and gender on skin vessel reactivity to endothelium-dependent and endothelium-independent vasodilators tested with iontophoresis and a laser Doppler perfusion imager. J Gerontol A Biol Sci Med Sci 1995;50:M121–M127.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.